BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27714671)

  • 21. Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers.
    Copson ER; White HE; Blaydes JP; Robinson DO; Johnson PW; Eccles DM
    BMC Cancer; 2006 Mar; 6():80. PubMed ID: 16563154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer.
    Citro S; Miccolo C; Medda A; Ghiani L; Tagliabue M; Ansarin M; Chiocca S
    J Exp Clin Cancer Res; 2022 Feb; 41(1):59. PubMed ID: 35144669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micronuclei and upper body cancers (head, neck, breast cancers) a systematic review and meta-analysis.
    Bolognesi C; Bruzzone M; Ceppi M; Marcon F
    Mutat Res Rev Mutat Res; 2021; 787():108358. PubMed ID: 34083052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.
    Gross M; Meirovich A; Rachmut J; Kalichman I; Peretz T; Eliashar R; Barak V
    Anticancer Res; 2016 Aug; 36(8):4347-52. PubMed ID: 27466555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of PTEN and its correlation with proliferation marker Ki-67 in head and neck cancer.
    Ahmed MW; Kayani MA; Shabbir G; Ali SM; Shinwari WU; Mahjabeen I
    Int J Biol Markers; 2016 May; 31(2):e193-203. PubMed ID: 26916897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma.
    Ye J; Zhang L; Li Z; Lin R; Song Y; Ni H; Gou X; Xie R
    Cancer Manag Res; 2021; 13():2733-2744. PubMed ID: 33790647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer.
    You GR; Chang JT; Li YL; Chen YJ; Huang YC; Fan KH; Chen YC; Kang CJ; Cheng AJ
    Front Oncol; 2021; 11():681717. PubMed ID: 34307149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer.
    van Dijk LV; Mohamed AS; Ahmed S; Nipu N; Marai GE; Wahid K; Sijtsema NM; Gunn B; Garden AS; Moreno A; Hope AJ; Langendijk JA; Fuller CD
    Eur J Cancer; 2023 Jan; 178():150-161. PubMed ID: 36442460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Expression Profile, Clinical Application and Potential Tumor Suppressing Mechanism of hsa_circ_0001675 in Head and Neck Carcinoma.
    Cao Y; Ye D; Shen Z; Li Z; Li Q; Rong H
    Front Oncol; 2022; 12():769666. PubMed ID: 35600372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma.
    Jahnson S; Karlsson MG
    Cancer; 2000 Aug; 89(3):619-29. PubMed ID: 10931462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy--Iranian Experience.
    Abolhasani M; Salarinejad S; Asgari M
    Asian Pac J Cancer Prev; 2015; 16(12):5043-7. PubMed ID: 26163638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Sinilnikova OM; Antoniou AC; Simard J; Healey S; Léoné M; Sinnett D; Spurdle AB; Beesley J; Chen X; ; Greene MH; Loud JT; Lejbkowicz F; Rennert G; Dishon S; Andrulis IL; ; Domchek SM; Nathanson KL; Manoukian S; Radice P; Konstantopoulou I; Blanco I; Laborde AL; Durán M; Osorio A; Benitez J; Hamann U; Hogervorst FB; van Os TA; Gille HJ; ; Peock S; Cook M; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Brewer C; ; Hughes DJ; Coupier I; Giraud S; Coulet F; Colas C; Soubrier F; Rouleau E; Bièche I; Lidereau R; Demange L; Nogues C; Lynch HT; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Sutter C; Deissler H; Schaefer D; Froster UG; ; Aittomäki K; Nevanlinna H; McGuffog L; Easton DF; Chenevix-Trench G; Stoppa-Lyonnet D;
    Br J Cancer; 2009 Oct; 101(8):1456-60. PubMed ID: 19707196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis.
    Zhang Y; Bai Y; Zhang Y; Guan J; Chen L
    Onkologie; 2012; 35(11):666-70. PubMed ID: 23147543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression patterns of carcinogen detoxifying genes (CYP1A1, GSTP1 & GSTT1) in HNC patients.
    Masood N; Kayani MA
    Pathol Oncol Res; 2013 Jan; 19(1):89-94. PubMed ID: 22918668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas.
    Valentin-Vega YA; Barboza JA; Chau GP; El-Naggar AK; Lozano G
    Hum Pathol; 2007 Oct; 38(10):1553-62. PubMed ID: 17651783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Prediction Models for Patients with Head and Neck Cancer among the Taiwanese Population.
    Yu MZ; Wu MM; Chien HT; Liao CT; Su MJ; Huang SF; Yeh CC
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Signature of Long Non-Coding RNA Associated with Areca Nut-Induced Head and Neck Cancer.
    Huang HH; You GR; Tang SJ; Chang JT; Cheng AJ
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model.
    Li CX; He Q; Wang ZY; Fang C; Gong ZC; Zhao HR; Ling B
    Head Neck; 2023 Oct; 45(10):2515-2524. PubMed ID: 37548087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.